Can Biotech Sustain the Venture Capital Investment Surge?

In 2017, the biotech sector experienced over $9.3 billion in venture funding in 471 deals, including several mega-deals such as Unity Biotechnology and ADC Therapeutics. While 2017 was, by far, one of the best years for biotech venture funding since 2010, the question is can that momentum continue through 2018?

Read More